Table 1 Summary of responses from 23 pathologists to postneoadjuvant chemotherapy breast cancer pathology reporting questionnaires

From: Pathologic reporting practices for breast cancer specimens after neoadjuvant chemotherapy—a survey of pathologists in academic institutions across the United States

Questionnaires

Yes

No

Do you grade tumors after neoadjuvant chemotherapy?

17

6

Do you routinely repeat hormone receptors HER2/Neu results after neoadjuvant chemotherapy?

15

8

If there are features of tumor regression/tumor bed at the margin but no actual tumor at the margin do you report this?a

11

8

Do you report number of nodes with fibrosis/changes of regression?

17

6

Do you report residual cancer burden score on your report or at least provide information on your report so clinicians can calculate residual cancer burden?

17

6

Do you have a specific synoptic for cases after neoadjuvant chemotherapy?

5

18

  1. aFour pathologists reported a variable practice
Back to article page